SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-077715
Filing Date
2022-07-06
Accepted
2022-07-06 16:30:30
Documents
14
Period of Report
2022-06-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2220394d1_8k.htm   iXBRL 8-K 31043
2 EXHIBIT 99.1 tm2220394d1_ex99-1.htm EX-99.1 15787
6 GRAPHIC tm2220394d1_ex99-1img01.jpg GRAPHIC 2435
  Complete submission text file 0001104659-22-077715.txt   232643

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA jagx-20220630.xsd EX-101.SCH 3063
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE jagx-20220630_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE jagx-20220630_pre.xml EX-101.PRE 22615
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2220394d1_8k_htm.xml XML 3604
Mailing Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104
Business Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104 415-371-8300
Jaguar Health, Inc. (Filer) CIK: 0001585608 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36714 | Film No.: 221069121
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences